David Schreiber

Schreiber has worked for over two decades as a consultant to private equity firms focused on healthcare companies. Prior to this, he served as chief financial officer and board member of Dianon Systems Inc. which was acquired by LabCorp, and at Quest Diagnostics. He has served on the boards of Specialty Labs, Nanogen Inc., Response Genetics, and Aspira Women’s Health.

  • October 2023

Added to: Agendia Inc. - Irvine, CA

Agendia is a gene expression profiling company advancing personalized early-stage breast cancer care.